Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > HALOS STOCK IS SO UNDERVALUED IT'S ALMOST UNBE

<< Previous

Bullboard Posts

Next >>

Comment by guerreiroon Nov 24, 2010 10:36pm

223 Views

Post# 17754884

RE: HALOS STOCK IS SO UNDERVALUED IT'S ALMOST UNBE

Good point Prospector 43; I agree with you::: this baby should be trading at $3 given the assets. Why is it being held back. Very simple HBM wants greater control and do not want the stock to runaway as there could be a plan for a PP and takeover and why not at the cheapest price. Yes; it is an interesting relationship between HLO and HBM and I wounder who the directors owe royalty to???. HLO or HBM ???, some of these guys are directors on both companies.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects